These analyses suggested ARID1A, CIC, EGFR, IDH1 and TP53 may act as tumour promoters in LGG, whereas FLG, KAT6B and PIK3R1 may act as tumour suppressors in LGG. This evidence concerns the gene TP53 and neoplasm.